PROFILE TRIAL: PREDICTING OUTCOMES FOR CROHN’S DISEASE USING A MOLECULAR BIOMARKER

(1) University of Cambridge School of Clinical Medicine,Department of Medicine,CBQQ,United Kingdom

(2) University of Exeter,Exeter IBD and Pharmacogenetics Research Group,EXDW,United Kingdom

(3) Nottingham University Hospitals NHS Trust,Department of Gastroenterology,NGHA,United Kingdom

(4) St Mark’s Hospital and Academic Institue,Gastroenterology,London,United Kingdom



This item was part of UEG Week 2017

This item can be cited as: United European Gastroenterology Journal 2017; 5 (Supplement 1)

Categorisation:

  • Format
    • Abstract
  • Year
    • 2017